Sherif Farag

  • 4092 Citations
  • 31 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sherif Farag is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants


Farag, S., Breueggemeier, R., Zwilling, B., Stephens, R., Minton, J., Grever, M., Tomie, D., Balcerzak, S., Powell, K., Yohn, D., Lemeshow, S., Bloomfield, C., Young, A., Young, A. P., Tsai, M., Ostrowski, M., Heerema, N. A., Paskett, E. D., Byrd, J., De La Chapelle, A., Plass, C., Ruymann, F., Kusewitt, D., Andersen, B. L., Croce, C., Schaaf, L., Marcucci, G., Jarjoura, D., Slater, M. D., Caligiuri, M., La Perle, K. M. D., Jewell, S. D., Single, N., Thomas, J., Parvin, J., Chalmers, J. J., Chan, K., Shapiro, C., Alder, H., Burry, R., Kuppusamy, P., Robertson, F., Jackson, R., Bruggemeier, R., Stoner, G., Kolattukudy, P., O'Dorisio, M. S., Basso, K., Trewyn, R., Brueggemeier, R., Young, D., Mull, L., Milo, G., Bruggemeier, R., Gams, R., Cschuller, D., Staubus, A., Schuller, D. & O'Dorisio, M. S.

National Institutes of Health


Project: Research project

  • Publications

    KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation

    Weisdorf, D., Cooley, S., Wang, T., Trachtenberg, E., Vierra-Green, C., Spellman, S., A. Sees, J., Spahn, A., Vogel, J., Fehniger, T. A., Woolfrey, A. E., Devine, S. M., Ross, M., Waller, E. K., Sobecks, R. M., McGuirk, J., Oran, B., Farag, S. S., Shore, T., Van Besien, K. & 4 others, Marsh, S. G. E., Guethlein, L. A., Parham, P. & Miller, J. S., Feb 25 2020, In : Blood Advances. 4, 4, p. 740-754 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • Pretransplant HLA typing revealed loss of heterozygosity in the major histocompatibility complex in a patient with acute myeloid leukemia

    Lobashevsky, A. L., Krueger-Sersen, M., Britton, R. M., Littrell, C. A., Singh, S., Cui, C. P., Kashi, Z., Martin, R. K., Breman, A. M., Vance, G. H. & Farag, S. S., Apr 2019, In : Human Immunology. 80, 4, p. 257-262 6 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation

    Farag, S. S., Nelson, R., Cairo, M. S., O'Leary, H. A., Zhang, S., Huntley, C., Delgado, D., Schwartz, J., Zaid, M. A., Abonour, R., Robertson, M. & Broxmeyer, H., Jan 1 2017, In : Oncotarget. 8, 66, p. 110350-110357 8 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations

    Immunotherapeutic concepts to target acute myeloid leukemia: Focusing on the role of monoclonal antibodies, hypomethylating agents and the leukemic microenvironment

    Gbolahan, O. B., Zeidan, A. M., Stahl, M., Zaid, M. A., Farag, S., Paczesny, S. & Konig, H., Aug 2017, In : International journal of molecular sciences. 18, 8, 1660.

    Research output: Contribution to journalReview article

  • 14 Scopus citations